CE - Celanese Corporation
NYSE
->
Basic Materials
->
Chemicals
Irving,
United States
Type: Equity
CE price evolution
CE
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1805 | $1357 | $1296 | $1167 |
| Short term investments | ||||
| Net receivables | $1784 | $1909 | $1963 | $2313 |
| Inventory | $2357 | $2337 | $2514 | $2749 |
| Total current assets | $6218 | $5887 | $6252 | $6448 |
| Long term investments | $1220 | $1245 | $1028 | $1049 |
| Property, plant & equipment | $6006 | $5862 | $5944 | $6002 |
| Goodwill & intangible assets | $10952 | $10935 | $11070 | $11225 |
| Total noncurrent assets | $20379 | $19651 | $19397 | $19642 |
| Total investments | $1220 | $1245 | $1028 | $1049 |
| Total assets | $26597 | $25538 | $25649 | $26090 |
| Current liabilities | ||||
| Accounts payable | $1510 | $1263 | $1243 | $1445 |
| Deferred revenue | ||||
| Short long term debt | $1383 | $1408 | $1507 | $1386 |
| Total current liabilities | $4072 | $3616 | $3922 | $3851 |
| Long term debt | $12626 | $12625 | $13236 | $13755 |
| Total noncurrent liabilities | $14973 | $14973 | $15639 | $16109 |
| Total debt | $14009 | $14033 | $14743 | $15141 |
| Total liabilities | $19045 | $18589 | $19561 | $19960 |
| Shareholders' equity | ||||
| Retained earnings | $12929 | $12308 | $11433 | $11289 |
| Other shareholder equity | -$744 | -$713 | -$702 | -$502 |
| Total shareholder equity | $7091 | $6491 | $5624 | $5661 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1805 | $1508 | $536 | $955 |
| Short term investments | $10 | $533 | ||
| Net receivables | $1784 | $2054 | $1667 | $1242 |
| Inventory | $2357 | $2808 | $1524 | $978 |
| Total current assets | $6218 | $6611 | $3807 | $3763 |
| Long term investments | $1220 | $1062 | $823 | $820 |
| Property, plant & equipment | $6006 | $5997 | $4429 | $4171 |
| Goodwill & intangible assets | $10952 | $11247 | $2147 | $1485 |
| Total noncurrent assets | $20379 | $19661 | $8168 | $7146 |
| Total investments | $1220 | $1062 | $833 | $1353 |
| Total assets | $26597 | $26272 | $11975 | $10909 |
| Current liabilities | ||||
| Accounts payable | $1510 | $1518 | $1160 | $797 |
| Deferred revenue | ||||
| Short long term debt | $1383 | $1306 | $791 | $496 |
| Total current liabilities | $4072 | $4068 | $2505 | $1973 |
| Long term debt | $12626 | $13373 | $3376 | $3435 |
| Total noncurrent liabilities | $14973 | $16099 | $4933 | $5041 |
| Total debt | $14009 | $15043 | $4167 | $3931 |
| Total liabilities | $19045 | $20635 | $7438 | $7014 |
| Shareholders' equity | ||||
| Retained earnings | $12929 | $11274 | $9677 | $8091 |
| Other shareholder equity | -$744 | -$518.02 | -$329 | -$328 |
| Total shareholder equity | $7091 | $5637 | $4189 | $3526 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2569 | $2723 | $2795 | $2853 |
| Cost of revenue | $1956 | $2050 | $2109 | $2222 |
| Gross Profit | $613 | $673 | $686 | $631 |
| Operating activities | ||||
| Research & development | $32 | $32 | $40 | $42 |
| Selling, general & administrative | $272 | $244 | $274 | $285 |
| Total operating expenses | $365 | -$169 | $366 | $386 |
| Operating income | $248 | $842 | $320 | $245 |
| Income from continuing operations | ||||
| EBIT | $301 | $893 | $398 | $298 |
| Income tax expense | -$575 | -$236 | -$4 | $25 |
| Interest expense | $178 | $178 | $182 | $182 |
| Net income | ||||
| Net income | $698 | $951 | $220 | $91 |
| Income (for common shares) | $698 | $951 | $220 | $91 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10940 | $9673 | $8537 | $5655 |
| Cost of revenue | $8337 | $7293 | $5855 | $4362 |
| Gross Profit | $2603 | $2380 | $2682 | $1293 |
| Operating activities | ||||
| Research & development | $146 | $112 | $86 | $74 |
| Selling, general & administrative | $1075 | $824 | $633 | $482 |
| Total operating expenses | $948 | $1001 | $738 | $624 |
| Operating income | $1655 | $1379 | $1944 | $669 |
| Income from continuing operations | ||||
| EBIT | $1890 | $1810 | $2311 | $2341 |
| Income tax expense | -$790 | -$489 | $330 | $247 |
| Interest expense | $720 | $405 | $91 | $109 |
| Net income | ||||
| Net income | $1960 | $1894 | $1890 | $1985 |
| Income (for common shares) | $1960 | $1894 | $1890 | $1985 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $698 | $951 | $220 | $91 |
| Operating activities | ||||
| Depreciation | $195 | $185 | $181 | $178 |
| Business acquisitions & disposals | $523 | $9 | ||
| Stock-based compensation | $4 | $4 | $18 | $14 |
| Total cash flows from operations | $830 | $403 | $762 | -$96 |
| Investing activities | ||||
| Capital expenditures | -$128 | -$131 | -$145 | -$164 |
| Investments | ||||
| Total cash flows from investing | -$168 | $375 | -$163 | -$178 |
| Financing activities | ||||
| Dividends paid | -$77 | -$76 | -$76 | -$76 |
| Sale and purchase of stock | ||||
| Net borrowings | -$163 | -$591 | -$365 | $31 |
| Total cash flows from financing | -$240 | -$700 | -$447 | -$69 |
| Effect of exchange rate | $26 | -$17 | -$23 | $2 |
| Change in cash and equivalents | $448 | $61 | $129 | -$341 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1960 | $1894 | $1890 | $1985 |
| Operating activities | ||||
| Depreciation | $739 | $478 | $378 | $356 |
| Business acquisitions & disposals | $532 | -$10541 | -$1115 | $1496 |
| Stock-based compensation | $40 | $60 | $95 | $28 |
| Total cash flows from operations | $1899 | $1819 | $1757 | $1343 |
| Investing activities | ||||
| Capital expenditures | -$568 | -$543 | -$467 | -$364 |
| Investments | $516 | -$501 | ||
| Total cash flows from investing | -$134 | -$11141 | -$1119 | $592 |
| Financing activities | ||||
| Dividends paid | -$305 | -$297 | -$304 | -$293 |
| Sale and purchase of stock | -$17 | -$1000 | -$650 | |
| Net borrowings | -$1088 | $10716 | $404 | -$472 |
| Total cash flows from financing | -$1456 | $10290 | -$1042 | -$1471 |
| Effect of exchange rate | -$12 | $4 | -$15 | $28 |
| Change in cash and equivalents | $297 | $972 | -$419 | $492 |
News
|
Brokerages Set Celanese Co. (NYSE:CE) PT at $147.22
ETF DAILY NEWS
12 Apr 2024
|
|
Here's Why You Should Retain Celanese (CE) in Your Portfolio
Zacks via Yahoo Finance
12 Apr 2024
|
|
When Should You Buy Celanese Corporation (NYSE:CE)?
Simply Wall St. via Yahoo Finance
12 Apr 2024
|
|
Celanese (NYSE:CE) PT Raised to $190.00
ETF DAILY NEWS
11 Apr 2024
|
|
Celanese (CE) Achieves Milestones in the Acetyl Chain Business
Zacks via Yahoo Finance
11 Apr 2024
|
|
Assenagon Asset Management S.A. Has $225,000 Stock Position in Celanese Co. (NYSE:CE)
ETF DAILY NEWS
9 Apr 2024
|
|
Vltava Fund Sold Celanese Corporation (CE) in Q1 as it Reached its Valuation
Insider Monkey via Yahoo Finance
8 Apr 2024
|
|
Celanese (CE) Up 39% in 6 Months: What's Driving the Rally?
Zacks via Yahoo Finance
3 Apr 2024
|
|
IFG Advisory LLC Boosts Holdings in Celanese Co. (NYSE:CE)
ETF DAILY NEWS
28 Mar 2024
|
|
Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol
Zacks via Yahoo Finance
25 Mar 2024
|
Fundamentals
| Market cap | $16.87B |
|---|---|
| Enterprise value | $29.07B |
| Shares outstanding | 108.86M |
| Revenue | $10.94B |
|---|---|
| EBITDA | $2.63B |
| EBIT | $1.89B |
| Net Income | $1.96B |
| Revenue Q/Q | 9.41% |
| Revenue Y/Y | N/A |
| P/E ratio | 8.61 |
|---|---|
| EV/Sales | 2.66 |
| EV/EBITDA | 11.06 |
| EV/EBIT | 15.38 |
| P/S ratio | 1.54 |
| P/B ratio | 2.15 |
| Book/Share | 71.98 |
| Cash/Share | 16.58 |
| EPS | $18.01 |
|---|---|
| ROA | 7.55% |
| ROE | 31.53% |
| Debt/Equity | 2.69 |
|---|---|
| Net debt/EBITDA | 6.56 |
| Current ratio | 1.53 |
| Quick ratio | 0.95 |